Timeline of Biosimilars Pathways
The EMA and European Commission (EC) drafts then publishes the Guideline on similar biological medicinal products, the first regulatory pathway and framework for the marketing authorization of biosimilars – setting the benchmark with its stringent guidelines for this new biopharmaceutical arena.
Read more...